- $17.77bn
- $16.82bn
- $3.94bn
- 89
- 29
- 80
- 73
Annual income statement for ITT, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | PRESS |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,765 | 2,988 | 3,283 | 3,631 | 3,939 |
| Cost of Revenue | |||||
| Gross Profit | 900 | 922 | 1,107 | 1,247 | 1,392 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2,261 | 2,520 | 2,756 | 2,955 | 3,254 |
| Operating Profit | 504 | 468 | 527 | 676 | 685 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 509 | 462 | 520 | 648 | 652 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 320 | 371 | 415 | 522 | 491 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 316 | 367 | 411 | 518 | 488 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 316 | 367 | 411 | 518 | 488 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 3.04 | 4.45 | 5.25 | 5.84 | 6.42 |
| Dividends per Share |